BRCA Gene Mutations and Prostate Cancer in Ashkenazi Men
Author Information
Author(s): S Lehrer, F Fodor, RG Stock, NN Stone, C Eng, HK Song, M McGovern
Primary Institution: Mount Sinai School of Medicine
Hypothesis
Do BRCA1 and BRCA2 mutations contribute to prostate cancer in Ashkenazi Jewish men?
Conclusion
The study found no BRCA1 or BRCA2 mutations in the 60 Ashkenazi men with prostate cancer, suggesting their contribution to prostate cancer incidence is likely small.
Supporting Evidence
- None of the 60 men studied carried the 185delAG or 6174delT mutations.
- A previous study found 16 out of 268 Ashkenazi Jewish women with breast cancer carried the mutations.
- The study suggests that the contribution of BRCA mutations to prostate cancer is likely limited to specific subgroups.
Takeaway
The researchers looked for specific gene mutations in men with prostate cancer but didn't find them, which means those mutations probably don't cause prostate cancer in these men.
Methodology
The study involved testing for BRCA1 and BRCA2 mutations in 60 Ashkenazi men with prostate cancer using DNA from blood samples.
Limitations
The study's findings may not apply to all populations, as it focused only on Ashkenazi Jewish men.
Participant Demographics
Participants were Ashkenazi Jewish men aged 55 to 80 years.
Statistical Information
P-Value
0.05
Statistical Significance
p=0.05
Want to read the original?
Access the complete publication on the publisher's website